Ysios Capital

Ysios Capital is a leading life sciences investor focused on financing highly innovative biotech companies worldwide. The firm provides resources to develop novel therapies for indications with high unmet medical needs, aiming to have a positive impact on patients and society. With a global outlook and proven performance, Ysios Capital manages over €400 million in assets and has invested in 40 companies, bringing 19 products to market and having over 70 products at the clinical stage.